DRUG REGIME FOR THE TREATMENT OF CEREBRAL ISCHEMIA

摘要

the present invention relates to the treatment of patients suffering from cerebral ischemia which is improved when the treatment employs a thrombolytic and an inhibitor against the signal transduction of the vascular endothelial growth factor receptor (vegf-rst) in a reduced dose in comparison with that used to treat cancer patients. treatment is also improved to allow use at the point of treatment by formulating protein drugs for long-term stability at room temperature, providing appropriate doses for the method and combining therapeutic agents with a point of care diagnosis for the integrity of the blood barrier of the brain.